Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack.

Neural regeneration research

Jiang D, Chu X, Hu L, Jiang S, Hu F, Sun J, Li C.
PMID: 25774185
Neural Regen Res. 2012 Feb 25;7(6):434-9. doi: 10.3969/j.issn.1673-5374.2012.06.005.

Patients with mild cognitive impairment after a transient ischemic attack were included in this study. They were treated with Yizhi Xingnao prescription, ergoloid mesylates or aspirin for 60 days. Evaluation using the Montreal Cognitive Assessment Scale showed that cognitive...

Cite
Jiang D, Chu X, Hu L, et al. Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack. Neural Regen Res. 2012;7(6):434-9doi: 10.3969/j.issn.1673-5374.2012.06.005.
Jiang, D., Chu, X., Hu, L., Jiang, S., Hu, F., Sun, J., & Li, C. (2012). Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack. Neural regeneration research, 7(6), 434-9. https://doi.org/10.3969/j.issn.1673-5374.2012.06.005
Jiang, Donglin, et al. "Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack." Neural regeneration research vol. 7,6 (2012): 434-9. doi: https://doi.org/10.3969/j.issn.1673-5374.2012.06.005
Jiang D, Chu X, Hu L, Jiang S, Hu F, Sun J, Li C. Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack. Neural Regen Res. 2012 Feb 25;7(6):434-9. doi: 10.3969/j.issn.1673-5374.2012.06.005. PMID: 25774185; PMCID: PMC4350129.
Copy Download .nbib Format: NLM
Perspectives in the treatment of vascular dementia.

Drugs of today (Barcelona, Spain : 1998)

Romàn G.
PMID: 12847569
Drugs Today (Barc). 2000 Sep;36(9):641-53. doi: 10.1358/dot.2000.36.9.593781.

The diagnosis and treatment of vascular dementia (VaD) are particularly challenging because of its multiple causal lesions and the variety of its clinical presentations. Even poststroke dementia cases may be due to preexisting Alzheimer's disease. Diagnostic criteria for clinical...

Cite
Romàn G. Perspectives in the treatment of vascular dementia. Drugs Today (Barc). 2000;36(9):641-53doi: 10.1358/dot.2000.36.9.593781.
Romàn, G. (2000). Perspectives in the treatment of vascular dementia. Drugs of today (Barcelona, Spain : 1998), 36(9), 641-53. https://doi.org/10.1358/dot.2000.36.9.593781
Romàn, G. "Perspectives in the treatment of vascular dementia." Drugs of today (Barcelona, Spain : 1998) vol. 36,9 (2000): 641-53. doi: https://doi.org/10.1358/dot.2000.36.9.593781
Romàn G. Perspectives in the treatment of vascular dementia. Drugs Today (Barc). 2000 Sep;36(9):641-53. doi: 10.1358/dot.2000.36.9.593781. PMID: 12847569.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries